BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17997267)

  • 1. Use of vouchers to reinforce abstinence and positive behaviors among clients in a drug court treatment program.
    Prendergast ML; Hall EA; Roll J; Warda U
    J Subst Abuse Treat; 2008 Sep; 35(2):125-36. PubMed ID: 17997267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcing Abstinence and Treatment Participation among Offenders in a Drug Diversion Program: Are Vouchers Effective?
    Hall EA; Prendergast ML; Roll JM; Warda U
    Crim Justice Behav; 2009; 36(9):935-953. PubMed ID: 20463918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dilemmas of coordinating treatment with criminal justice.
    Lissner AR; Gilmore J; Pompi KF
    Am J Drug Alcohol Abuse; 1976; 3(4):621-8. PubMed ID: 1036446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
    Silverman K; Higgins ST; Brooner RK; Montoya ID; Cone EJ; Schuster CR; Preston KL
    Arch Gen Psychiatry; 1996 May; 53(5):409-15. PubMed ID: 8624184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
    Preston KL; Umbricht A; Epstein DH
    Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Los Angeles County drug court programs: initial results.
    Fielding JE; Tye G; Ogawa PL; Imam IJ; Long AM
    J Subst Abuse Treat; 2002 Oct; 23(3):217-24. PubMed ID: 12392808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Order in The Court? The Association Between Substance Use, Exposure to Violence, Risky Sexual Behaviors & Observed Court Behaviors Among Women Involved in the Criminal Justice System.
    Jones AA; Gerke T; Ennis N; Striley CW; Crecelius R; Sullivan JE; Cottler LB
    J Natl Med Assoc; 2019 Apr; 111(2):134-147. PubMed ID: 30409715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug courts: a primer for the family physician.
    Lessenger JE; Roper GF
    J Am Board Fam Pract; 2002; 15(4):298-303. PubMed ID: 12150463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status hearings in drug court: when more is less and less is more.
    Festinger DS; Marlowe DB; Lee PA; Kirby KC; Bovasso G; McLellan AT
    Drug Alcohol Depend; 2002 Oct; 68(2):151-7. PubMed ID: 12234644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOPE-ful bottles: Examining the potential for Hawaii's opportunity probation with enforcement (HOPE) to help mainstream therapeutic jurisprudence.
    Bartels L
    Int J Law Psychiatry; 2019; 63():26-34. PubMed ID: 29958679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for drug-using offenders with co-occurring mental health problems.
    Perry AE; Martyn-St James M; Burns L; Hewitt C; Glanville JM; Aboaja A; Thakkar P; Santosh Kumar KM; Pearson C; Wright K; Swami S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD010901. PubMed ID: 31588993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile drug courts: emerging outcomes and key research issues.
    Henggeler SW
    Curr Opin Psychiatry; 2007 May; 20(3):242-6. PubMed ID: 17415076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of drug treatment courts in Australia.
    Makkai T
    Subst Use Misuse; 2002; 37(12-13):1567-94. PubMed ID: 12487234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of the impact of adult drug-treatment courts.
    Brown RT
    Transl Res; 2010 Jun; 155(6):263-74. PubMed ID: 20478542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk offenders participating in court-supervised substance abuse treatment: characteristics, treatment received, and factors associated with recidivism.
    Evans E; Huang D; Hser YI
    J Behav Health Serv Res; 2011 Oct; 38(4):510-25. PubMed ID: 21479770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining Individual Characteristics and Program Performance to Understand Two-Year Recidivism Rates Among Drug Court Participants: Comparing Graduates and Terminators.
    Shannon LM; Jones AJ; Newell J; Payne C
    Int J Offender Ther Comp Criminol; 2018 Oct; 62(13):4196-4220. PubMed ID: 29706118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are effective drug courts an urban phenomenon?: considering their impact on recidivism among a nonmetropolitan adult sample in Washington State.
    Galloway AL; Drapela LA
    Int J Offender Ther Comp Criminol; 2006 Jun; 50(3):280-93. PubMed ID: 16648383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Client and program factors associated with dropout from court mandated drug treatment.
    Evans E; Li L; Hser YI
    Eval Program Plann; 2009 Aug; 32(3):204-12. PubMed ID: 19150133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of court-mandated substance abuse treatment on clinical decision making.
    Niv N; Hamilton A; Hser YI
    J Behav Health Serv Res; 2009 Oct; 36(4):505-16. PubMed ID: 18618265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of voucher exchanges between criminal justice involved and noninvolved participants enrolled in voucher-based contingency management drug abuse treatment programs.
    Roll JM; Prendergast ML; Sorensen K; Prakash S; Chudzynski JE
    Am J Drug Alcohol Abuse; 2005; 31(3):393-401. PubMed ID: 16161725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.